FDA Hits Texas Drug Facility for Oversight of Pilot/Exhibit Batches

The FDA cited Sovereign Pharmaceuticals for quality and other failures observed during a Dec. 11-19 inspection of its facility in Fort Worth, Texas—including its failure to ensure the quality of pilot or exhibit batches.
Source: Drug Industry Daily